FITC Anti-Human CD44 Antibody
英诺赛图(InnoCyto)的 FITC Anti-Human CD44 Antibody(克隆 BJ18) 为鼠源 IgG1 单克隆抗体,靶向 CD44(别名 H-CAM 等),FITC 标记(488 nm 蓝色激光激发),适用于流式细胞术。提供 25 tests、100 tests 规格,目录价 ¥1,015 起,仅供科研使用(RUO)。
01产品图片

02产品简介
英诺赛图(InnoCyto)的 FITC Anti-Human CD44 Antibody(克隆 BJ18) 为鼠源 IgG1 单克隆抗体,靶向 CD44(别名 H-CAM 等),FITC 标记(488 nm 蓝色激光激发),适用于流式细胞术。提供 25 tests、100 tests 规格,目录价 ¥1,015 起,仅供科研使用(RUO)。
03产品介绍
规格与货号
120303 | 25 tests | ¥1,015
120304 | 100 tests | ¥2,235
Product Details
Regulatory Status|RUO
Protein Concentration|Supplied at a lot-specific concentration.
Storage & Handling|The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Recommended Usage|For flow cytometric staining, it is recommended to use 5 µL of this reagent per 0.5-1.0 million cells in a 100 µL volume. Optimal reagent performance should be determined by titration for each specific application. FITC has an excitation max at 493 nm and an emission max at 525 nm.
See All Formats|Clone BJ18
Background Information
Human CD44 is a widely expressed type I transmembrane glycoprotein that functions as a cell adhesion molecule involved in cell-cell and cell-extracellular matrix interactions. It is expressed on numerous cell types, including leukocytes, epithelial cells, fibroblasts, endothelial cells, and many stem cells. CD44 regulates a broad range of biological processes, including lymphocyte activation and homing, leukocyte migration, tissue repair, hematopoiesis, and wound healing. Through its ability to mediate adhesion and intracellular signaling, CD44 also influences cell proliferation, survival, differentiation, and motility.
Structurally, CD44 consists of an extracellular N-terminal hyaluronan-binding domain, a stem region that undergoes extensive alternative splicing, a single transmembrane domain, and a cytoplasmic tail that interacts with cytoskeletal adaptor proteins such as ezrin, radixin, and moesin (ERM proteins). Alternative splicing generates numerous CD44 variant isoforms (CD44v), which differ in their extracellular domains and tissue distribution. The principal ligand for CD44 is hyaluronic acid (hyaluronan), a major component of the extracellular matrix. CD44 also binds osteopontin, fibronectin, collagen, laminin, matrix metalloproteinases, and select growth factors, allowing it to integrate extracellular matrix remodeling with intracellular signaling pathways.
CD44 has been implicated in numerous inflammatory, autoimmune, and malignant diseases. In chronic inflammatory disorders such as rheumatoid arthritis and inflammatory bowel disease, CD44 contributes to leukocyte recruitment and tissue inflammation. In cancer, CD44 is frequently overexpressed and serves as a marker of cancer stem cells in multiple tumor types, including breast, colorectal, pancreatic, gastric, and head and neck cancers. CD44 promotes tumor cell proliferation, epithelial-mesenchymal transition, invasion, metastasis, resistance to chemotherapy, and tumor recurrence through signaling pathways involving Ras, PI3K/AKT, Wnt/β-catenin, and receptor tyrosine kinases. Consequently, CD44 has emerged as an attractive therapeutic target. Investigational strategies include monoclonal antibodies, hyaluronan-targeted drug delivery systems, antibody-drug conjugates, nanoparticle-based therapies, CAR T-cell approaches, and inhibitors that disrupt CD44-hyaluronan interactions. These therapies aim to selectively eliminate CD44-expressing tumor cells, overcome drug resistance, and enhance the effectiveness of conventional cancer treatments while preserving normal tissue function.
Data Sheets
Human peripheral blood lymphocytes were stained with FITC Anti-Human CD44 clone BJ18 (color-filled histogram) or an isotype control (gray histogram).
04完整参数表
参数由厂商资料整理,采购前请以最终报价单与技术协议为准。
05荣誉与资质
该品牌暂未上传荣誉证书与资质文件。以下是平台可核验的公开信息,未上传项如实标注,不做推断。
- 营业执照未上传
- 品牌授权未上传
- 产品检测报告未上传
- 会员身份
- 收费会员
- 经营身份
- 原厂
- 成立年份
- 2020 年
- 所在地
- 上海
- 收录条目
- 1865 个
- 平台核验
- 平台代管
06品牌与供应商
InnoCyto(上海英诺赛图生物科技有限公司)致力于通过开发高质量细胞分析试剂,加速科学发现进程。公司为研究人员提供细胞层面探索所需的工具,推动免疫学、肿瘤学等多领域的研究创新。 核心团队拥有丰富的行业经验,曾参与全球头部生命科学公司的标杆项目搭建,深刻理解工业界与学术研究的前沿需求。试剂从设计之初即以精确性、一致性、高性能为核心标准,让科学家能把精力集中在最核心的研究工作上。 公司将深厚的科学积累与对品质的严格承诺相结合,力争成为全球研究人员信赖的合作伙伴。产品线覆盖经验证的一抗与二抗、同型对照、生物类似药抗体、重组蛋白、细胞因子、免疫检测试剂盒及配套试剂,并提供重组蛋白/抗体表达与标记偶联服务。
品牌资料由厂商公开信息与授权渠道核对整理;条目参数与价格以最终报价单为准。
07同类条目
同一子类内的条目才具备可比性。跨子类比较参数通常没有意义。
08同品牌其他条目
上海英诺赛图 在本目录共 1865 个条目,除本条外还有:
科研在线(TeleVM). FITC Anti-Human CD44 Antibody(120303)[EB/OL]. 产品目录, 2026-11-12. https://www.suprotek.cn/products/item/fitc-anti-human-cd44-antibody.html.
TeleVM. (2026, November 12). FITC Anti-Human CD44 Antibody(120303). 产品目录. https://www.suprotek.cn/products/item/fitc-anti-human-cd44-antibody.html
@misc{biocsp_item_fitc_anti_human_cd44_antibody,
title = {FITC Anti-Human CD44 Antibody(120303)},
author = {{科研在线}},
year = {2026},
howpublished = {产品目录},
note = {更新于 2026-11-12,产品目录},
url = {https://www.suprotek.cn/products/item/fitc-anti-human-cd44-antibody.html}
}
GB/T 7714 用于中文论文与报告;APA 7 用于英文期刊;BibTeX 可直接导入 Zotero、EndNote 或 LaTeX。
许可:CC BY-NC 4.0 · 转载注明来源